Finally, a set of promising compounds were highlighted as potential SIRT1 activators (Figure 7(Fig. 7)) to be further developed for Alzheimer's disease, other aging diseases, and other relevant therapeutics. This evidence concerns the gene SIRT1 and Alzheimer disease.